Investigational Site 887 — Jasper, Alabama

Investigational Site 887 is a clinical research site located in Jasper, Alabama, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 887 has participated in 1 clinical trials.

Therapeutic areas: Eosinophilic Asthma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jasper

Browse all research sites in Alabama · View every site in Jasper

• GSK Investigational Site
• Research Site
• Jasper Summit Research
• Novartis Investigative Site
• Novartis Investigator Site
• Forest Investigative Site 2088
• Pfizer Investigational Site
• Alabama Back Institute
• Pearl Investigative Site
• Pulmonary & Sleep Associates of Jasper, PC
• 1199.32.10029 Boehringer Ingelheim Investigational Site
• 1222.40.11003 Boehringer Ingelheim Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 887?

Investigational Site 887 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 887 conducted?

Investigational Site 887 has 1 clinical trials on record. Their work covers Eosinophilic Asthma.

Is Investigational Site 887 accredited by Crixeo Clinical Trials?

Investigational Site 887 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 887?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.